Leukemia: all 5,475 studies
Page 22 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/LymphomaWithdrawnNCT05613348Phase 1/2
- Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I MutationCompletedNCT05611216
- N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric LeukemiaTerminatedNCT05611086Phase 4
- The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or Without Sorafenib MaintenanceStatus unknownNCT05601895
- The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCTStatus unknownNCT05596981
- The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCTStatus unknownNCT05596968
- Mobile Intervention to Improve Adherence of Oral Anti-cancer Medications Among Acute Myeloid Leukemia Patients, the txt4AML StudyWithdrawnNCT05595135Not applicable
- Olverembatinib Combined With Reduced-Intensity Chemotherapy and Venetoclax for de Novo Ph+ ALLCompletedNCT05594784Phase 2
- A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesActive, not recruitingNCT05589896Phase 1/2
- Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)Status unknownNCT05587088Phase 1/2
- Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALLStatus unknownNCT05578378Phase 2/3
- An Open, Single Center, Randomized Controlled Clinical Study of UCB (Cord Blood) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)Status unknownNCT05577611Phase 1
- Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid LeukemiaStatus unknownNCT05574608Early Phase 1
- Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALLWithdrawnNCT05571540Phase 1/2
- Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AMLTerminatedNCT05569512Phase 1
- Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic LeukemiaCompletedNCT05563545Phase 1
- Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALLCompletedNCT05557110Phase 2
- LILRB4 STAR-T Cells in the Treatment of R/R AML/CMMLCompletedNCT05548088Phase 1
- "Peripheral Blood Dipeptidylpeptidase IV (CD26) Positive Leukemic Stem Cells in Chronic Myeloid Leukemia as a Diagnostic Marker"Status unknownNCT05543161
- A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic MarkersCompletedNCT05541224
- A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute LeukemiasWithdrawnNCT05521087Phase 1
- STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL AmyloidosisWithdrawnNCT05519527Phase 1
- LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT05518357Phase 1
- A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLLTerminatedNCT05515406Phase 1
- Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With HemoblastosisActive, not recruitingNCT05515029Phase 3
- Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid MalignanciesWithdrawnNCT05513612Phase 1
- Clinical Characters and Outcome of Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56 ExpressionStatus unknownNCT05512104
- Psychological Mobile App for Patients With AMLTerminatedNCT05501171Not applicable
- Healthcare Resource Utilization in Adults Diagnosed With Acute Myeloid Leukemia (AML)CompletedNCT05488613
- Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/LymphomaWithdrawnNCT05487495Phase 1
- Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT05480501Early Phase 1
- Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaActive, not recruitingNCT05479994Phase 2
- Study of Let-7a and miRNA-124 in Cases of Non-Hodgkin's Lymphoma and Acute LeukemiaStatus unknownNCT05477667Not applicable
- Study Conducted Among Patients With CMLCompletedNCT05476562
- Phase I Clinical Trial of RC1012 Injection in Patients With r/r AMLStatus unknownNCT05471323Phase 1
- A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)CompletedNCT05470140Phase 1
- Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLLWithdrawnNCT05465876Phase 2
- Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid LeukemiaCompletedNCT05458258
- A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDSWithdrawnNCT05456269Phase 1
- Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AMLCompletedNCT05456048
- Information Support Using an Online Learning Platform for Malaysian Pediatric Leukemia and Lymphoma ParentsCompletedNCT05455268Not applicable
- G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCTStatus unknownNCT05449899Phase 2/3
- A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDSStatus unknownNCT05448599Phase 1/2
- Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid LeukemiaStatus unknownNCT05445765Phase 1
- TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) PatientsActive, not recruitingNCT05434312Phase 1
- Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP PatientsCompletedNCT05433532Phase 2
- Expression of Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PDL-1) in Acute Lymphoblastic Leukemia in PediatricStatus unknownNCT05428111Not applicable
- Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic SyndromesStatus unknownNCT05426798Phase 1
- Granulocyte Transfusions After Umbilical Cord Blood TransplantActive, not recruitingNCT05425043Not applicable
- Special Drug Use-results Surveillance of Scemblix TabletsCompletedNCT05421091
- Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic LeukemiaTerminatedNCT05410574Not applicable
- Study of Radiolabeled Revumenib in Adults With Acute LeukemiaCompletedNCT05406817Phase 1
- Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AMLStatus unknownNCT05404516Phase 2
- Dynamic Changes in the Levels of sCD62L and SPARC in Chronic Myeloid Leukemia Patients During Imatinib TreatmentCompletedNCT05387330
- FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.Status unknownNCT05383014
- Decitabine and HQP1351-based Chemotherapy Regimen for the Treatment Advanced CMLStatus unknownNCT05376852Phase 2
- A Study of Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS ParticipantsWithdrawnNCT05367401Phase 1/2
- Combination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy for Acute Myeloid LeukemiaStatus unknownNCT05362942Phase 2
- Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLLTerminatedNCT05360238Phase 1/2
- Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid LeukemiaActive, not recruitingNCT05356169Phase 2/3
- First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic MalignanciesTerminatedNCT05348889Phase 1/2
- A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid LeukemiaTerminatedNCT05345938Phase 1/2
- Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Patients With Acute LeukemiaStatus unknownNCT05335226Not applicable
- Donor Immune Cell Therapy for Acute Myeloid LeukemiaStatus unknownNCT05333705Phase 1
- GM-CLAG in Relapsed/Refractory FLT3-mutated AMLWithdrawnNCT05330377Phase 1
- Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid LeukemiaStatus unknownNCT05330364Phase 2
- Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic LeukemiaStatus unknownNCT05326984Not applicable
- A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute LeukemiaCompletedNCT05326516Phase 1
- Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory LeukemiasWithdrawnNCT05321940Phase 1
- A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatWithdrawnNCT05320380Phase 1/2
- Real World Outcomes Using Novel Agents for AML in the UKStatus unknownNCT05312112
- A Long-term Follow-up Study of Patients Who Received VOR33TerminatedNCT05309733
- Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid AcidStatus unknownNCT05297123Phase 1
- A Triple-targeted Cell Preparation Targeting CD19/CD20/CD22 in Patients With Relapsed/Refractory B-cell Acute Lymphocytic LeukemiaTerminatedNCT05292898Phase 1
- Pyronaridine in Acute Myeloid Leukemia (AML)SuspendedNCT05291390Phase 2
- Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell MalignanciesCompletedNCT05290155Phase 1
- A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLLTerminatedNCT05272813Phase 1/2
- A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic LeukemiaTerminatedNCT05268003Phase 2
- Safety and Efficacy Study of CI-135 CAR-T Cells in Subjects with Relapsed or Refractory Acute Myeloid LeukemiaWithdrawnNCT05266950Phase 1
- MargheRITA (Remote Intelligence for Therapeutic Adherence)CompletedNCT05260203Not applicable
- Phase I Study of JWCAR029 in Subjects With R/R CLL/SLLWithdrawnNCT05259813Phase 1
- Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive ChemotherapyStatus unknownNCT05249894
- Optimized Dual CD33/CLL1 CAR T Cells in Subjects With Refractory or Relapsed Acute Myeloid LeukemiaWithdrawnNCT05248685Phase 1
- NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT05247957Not applicable
- A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTerminatedNCT05244070Phase 1
- Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)Active, not recruitingNCT05237245
- Emotion and Symptom-focused Engagement for Caregivers (EASE-CG) Pilot StudyCompletedNCT05236296Not applicable
- Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid TumorsCompletedNCT05225584Phase 1
- Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB)TerminatedNCT05223699Phase 1
- To Evaluate the Safety and Tolerability of Human CD19-CD22 Targeted T Cells Injection for Subjects With R/R B-ALL.Status unknownNCT05223686Phase 1
- Managed Access Programs for PKC412, MidostaurinNo longer availableNCT05219266
- A Study of Azacitidine in Participants With International Prognostic Scoring System (IPSS) Intermediate-2 and High-risk Myelodysplastic Syndromes (MDS), or Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)CompletedNCT05218902
- Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid LeukemiaStatus unknownNCT05215015Early Phase 1
- CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ LymphomaStatus unknownNCT05212584Phase 1
- Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of EpcoritamabActive, not recruitingNCT05206357Phase 1
- A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AMLActive, not recruitingNCT05199051Phase 2
- CAV Regimen Bridging to HSCT for R/R ALCompletedNCT05190549Phase 2
- Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly PatientsCompletedNCT05188326Phase 3
- Cryopreserved MMUD BM With PTCy for Hematologic MalignanciesWithdrawnNCT05170828Phase 1
- A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)SuspendedNCT05168904Phase 1/2